Related Experiment Video
Updated: Oct 6, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Braking Time and Cognitive, Visual, and Motor Determinants in Older Drivers With Type 2 Diabetes Mellitus With and
Vivian Rodrigues de Matos Souza1, Matheus Henrique Dos Santos Lino1, Julia Maria D'Andréa Greve2
1Graduate Program in Aging Sciences at University São Judas Tadeu, São Paulo, Brazil.
Background:
Driving is a complex task that requires efficient integration of sensorimotor, visual, and cognitive systems. Although diabetic peripheral neuropathy (DPN) is associated with reduced driving performance, the impact of this condition when combined with aging is still poorly understood.
Aims:
To assess braking time in older drivers with Type 2 diabetes mellitus (T2DM), with and without DPN, comparing them with a control group and investigating associations with motor, cognitive, and visual characteristics.
Methods:
Cross-sectional study involving individuals aged 60-79 years, distributed into three groups: T2DM without DPN (n = 17), T2DM with DPN (n = 22), and control (n = 25). DPN was identified using the Michigan Neuropathy Screening Instrument, Brazilian version (MNSI-Brazil), with a cutoff score ≥ 2.5. Cognitive (Montreal Cognitive Assessment-MoCA, cognitive TUG), visual (acuity, stereopsis, color vision, and adaptometry), and motor assessments (handgrip strength and plantar flexor strength) were performed, along with a driving simulation.
Results:
Older adults with T2DM showed longer braking times than the control group (p < 0.01), regardless of the presence of DPN. Participants with DPN presented lower upper-limb strength (p = 0.01) and reduced strength of the right plantar flexor muscles (p < 0.01). Braking time was influenced by sex and plantar strength.
Conclusion:
T2DM is associated with increased braking time in older adults, and reduced plantar flexor muscle strength, particularly among women, highlights the need for monitoring and targeted muscle strengthening to preserve driving safety and autonomy.
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes III: Clinical Manifestations
